Literature DB >> 35982046

Engineering an autonomous VH domain to modulate intracellular pathways and to interrogate the eIF4F complex.

Yuri Frosi1,2, Yen-Chu Lin1,3,4, Jiang Shimin1,2, Siti Radhiah Ramlan1,2, Kelly Hew5,6, Alf Henrik Engman5,6, Anil Pillai5,6, Kit Yeung5,6, Yue Xiang Cheng5,6, Tobias Cornvik6, Par Nordlund5,6,7, Megan Goh1, Dilraj Lama8, Zachary P Gates2,9, Chandra S Verma6,10,11, Dawn Thean1, David P Lane1, Ignacio Asial12,13, Christopher J Brown14,15.   

Abstract

An attractive approach to target intracellular macromolecular interfaces and to model putative drug interactions is to design small high-affinity proteins. Variable domains of the immunoglobulin heavy chain (VH domains) are ideal miniproteins, but their development has been restricted by poor intracellular stability and expression. Here we show that an autonomous and disufhide-free VH domain is suitable for intracellular studies and use it to construct a high-diversity phage display library. Using this library and affinity maturation techniques we identify VH domains with picomolar affinity against eIF4E, a protein commonly hyper-activated in cancer. We demonstrate that these molecules interact with eIF4E at the eIF4G binding site via a distinct structural pose. Intracellular overexpression of these miniproteins reduce cellular proliferation and expression of malignancy-related proteins in cancer cell lines. The linkage of high-diversity in vitro libraries with an intracellularly expressible miniprotein scaffold will facilitate the discovery of VH domains suitable for intracellular applications.
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35982046      PMCID: PMC9388512          DOI: 10.1038/s41467-022-32463-1

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   17.694


  69 in total

1.  Creating random mutagenesis libraries using megaprimer PCR of whole plasmid.

Authors:  Kentaro Miyazaki; Misa Takenouchi
Journal:  Biotechniques       Date:  2002-11       Impact factor: 1.993

2.  Single domain intracellular antibodies: a minimal fragment for direct in vivo selection of antigen-specific intrabodies.

Authors:  Tomoyuki Tanaka; M Natividad Lobato; Terence H Rabbitts
Journal:  J Mol Biol       Date:  2003-08-29       Impact factor: 5.469

3.  Improving antibody binding affinity and specificity for therapeutic development.

Authors:  Jenny Bostrom; Chingwei V Lee; Lauric Haber; Germaine Fuh
Journal:  Methods Mol Biol       Date:  2009

4.  Antibody scFv fragments without disulfide bonds made by molecular evolution.

Authors:  K Proba; A Wörn; A Honegger; A Plückthun
Journal:  J Mol Biol       Date:  1998-01-16       Impact factor: 5.469

5.  Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F.

Authors:  Regina Cencic; David R Hall; Francis Robert; Yuhong Du; Jaeki Min; Lian Li; Min Qui; Iestyn Lewis; Serdar Kurtkaya; Ray Dingledine; Haian Fu; Dima Kozakov; Sandor Vajda; Jerry Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-29       Impact factor: 11.205

6.  eIF4E--from translation to transformation.

Authors:  Yaël Mamane; Emmanuel Petroulakis; Liwei Rong; Kaori Yoshida; Lian Wee Ler; Nahum Sonenberg
Journal:  Oncogene       Date:  2004-04-19       Impact factor: 9.867

7.  An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly.

Authors:  A Wörn; A Plückthun
Journal:  FEBS Lett       Date:  1998-05-15       Impact factor: 4.124

8.  Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma.

Authors:  Michaël Cerezo; Ramdane Guemiri; Sabine Druillennec; Isabelle Girault; Hélène Malka-Mahieu; Shensi Shen; Delphine Allard; Sylvain Martineau; Caroline Welsch; Sandrine Agoussi; Charlène Estrada; Julien Adam; Cristina Libenciuc; Emilie Routier; Séverine Roy; Laurent Désaubry; Alexander M Eggermont; Nahum Sonenberg; Jean Yves Scoazec; Alain Eychène; Stéphan Vagner; Caroline Robert
Journal:  Nat Med       Date:  2018-10-29       Impact factor: 53.440

9.  NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies.

Authors:  Sandrine Moutel; Nicolas Bery; Virginie Bernard; Laura Keller; Emilie Lemesre; Ario de Marco; Laetitia Ligat; Jean-Christophe Rain; Gilles Favre; Aurélien Olichon; Franck Perez
Journal:  Elife       Date:  2016-07-19       Impact factor: 8.140

Review 10.  Nanobodies Right in the Middle: Intrabodies as Toolbox to Visualize and Modulate Antigens in the Living Cell.

Authors:  Teresa R Wagner; Ulrich Rothbauer
Journal:  Biomolecules       Date:  2020-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.